PIK3CA and cancer: Furthermore, a 2013 study assessing twenty signaling pathways across twelve major cancer types found that 52.2% of EC samples harbored PIK3CA mutations, 30.9% had PIK3R1 mutations, and 63.5% had PTEN mutations (11).